explore -WSS

explore

author：explore 2025-10-01 18:45:14 - browse：2489

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Startling documents reveal new facets of Sacklers' opioid empire

entertainment

WSS

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Stanford president's case begs question: Who takes blame?

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

First Opinion Podcast: What happens when kids become caregivers?

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Driven by the pandemic, applicants flood public health schools

hotspot

explore

explore

The cancer drug shortage isn’t new — and neither are the solutions

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Supreme Court strikes down use of affirmative action

Tesla recalling nearly 16,000 of its 2021

The high cost of giving birth even with insurance

Tesla recalling nearly 16,000 of its 2021

Tori Bowie and the unacceptable rates of Black maternal death

Akili, maker of video game for ADHD, to be acquired for 34 million

Virginia high school admissions case could be legal follow

Tesla recalling nearly 16,000 of its 2021

leisure time

Hospitals struggle to profit from CAR

AI used to predict Covid

Indian pharmaceutical industry in denial over drug

Lab trade group sues FDA to halt regulation of lab

Akili, maker of video game for ADHD, to be acquired for 34 million

EF3 tornado rips through North Carolina amid extreme weather nationwide

hotspot

Wikipedia

entertainment

entertainment